سبحان دارو
دسبحان | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 21,730 1.94
Close Price: 21,570
Balance Sheet
AGM
Interim
2026/05/13 Fiscal Year 2025/12/2112 Month | 2025/03/15 Fiscal Year 2024/12/2012 Month | 2024/05/19 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 801.585 Billion | 246.954 Billion | 193.575 Billion | |
Trade Receivables | 28.012 Trillion | 19.19 Trillion | 15.123 Trillion | |
Prepayments | 3.39 Trillion | 1.634 Trillion | 1.607 Trillion | |
Raw Materials & Packaging Inventory | 4.77 Trillion | 5.107 Trillion | 3.633 Trillion | |
Work-in-Progress Inventory | 1.137 Trillion | 700.605 Billion | 728.607 Billion | |
Finished Goods Inventory | 379.916 Billion | 30.866 Billion | 209.993 Billion | |
Spare Parts Inventory | 363.797 Billion | 215.487 Billion | 174.172 Billion | |
Goods in Transit | 831.608 Billion | 378.952 Billion | 2.364 Trillion | |
Other Inventories | 7.166 Billion | - | - | |
Inventories | 7.486 Trillion | 6.431 Trillion | 7.094 Trillion | |
Total Current Assets | 39.689 Trillion | 27.502 Trillion | 24.018 Trillion | |
Long-Term Investments | 394.176 Billion | 450.892 Billion | 524.518 Billion | |
Long-Term Trade Receivables | 44.23 Billion | 30.25 Billion | 34.088 Billion | |
Intangible Assets | 11.56 Billion | 10.399 Billion | 10.408 Billion | |
Property, Plant & Equipment | 7.348 Trillion | 5.678 Trillion | 3.753 Trillion | |
Net Fixed Assets | 7.348 Trillion | 5.678 Trillion | 3.753 Trillion | |
Total Non-Current Assets | 7.798 Trillion | 6.169 Trillion | 4.322 Trillion | |
Total Assets | 47.488 Trillion | 33.671 Trillion | 28.341 Trillion | |
Trade Payables | 10.031 Trillion | 5.709 Trillion | 5.127 Trillion | |
Advances Received | - | 32.092 Billion | 32.684 Billion | |
Income Tax Provision | 1.399 Trillion | 1.361 Trillion | 1.874 Trillion | |
Other Provisions | 114.127 Billion | - | - | |
Proposed & Payable Dividends | 1.226 Trillion | 3.194 Trillion | 898.444 Billion | |
Current Borrowings | 9.953 Trillion | 9.497 Trillion | 6.472 Trillion | |
Total Current Liabilities | 22.724 Trillion | 19.794 Trillion | 14.403 Trillion | |
Long-Term Borrowings | 6 Trillion | 3 Trillion | 3 Trillion | |
Employee Termination Benefits Provision | 1.095 Trillion | 792.553 Billion | 615.077 Billion | |
Total Non-Current Liabilities | 7.095 Trillion | 3.793 Trillion | 3.615 Trillion | |
Total Liabilities | 29.819 Trillion | 23.586 Trillion | 18.018 Trillion | |
Capital | 10 Trillion | 6.82 Trillion | 5.33 Trillion | |
Retained Earnings | 6.74 Trillion | 2.751 Trillion | 4.635 Trillion | |
Legal Reserve | 948.536 Billion | 682 Billion | 533 Billion | |
Share Premium Reserve | -19.819 Billion | -168.207 Billion | -175.624 Billion | |
Total Equity | 17.668 Trillion | 10.085 Trillion | 10.322 Trillion | |
Total Liabilities & Equity | 47.488 Trillion | 33.671 Trillion | 28.341 Trillion | |
Approved Capital | 10 Trillion | 6.82 Trillion | 5.33 Trillion | |
Approved Retained Earnings | 5.14 Trillion | 1.728 Trillion | 1.49 Trillion | |
Approved Legal Reserve | 948.536 Billion | 682 Billion | 533 Billion | |
Total Approved Equity (at AGM) | 16.088 Trillion | 9.23 Trillion | 7.353 Trillion | |
کالای امانی دیگران نزد ما | 3.146 Billion | 991 Million | 16.237 Billion |
